In conclusion, COPD is a global disease, with increasing prevalence and health-related impact. The loss of FEV 1 may be slowing down, but what is really needed is an intervention that improves it in ...

Obstructive pulmonary disease is a collective term for refractory respiratory diseases with chronic airway inflammation and excessive mucus retention that are accompanied by airway obstruction. They ...

Merck completes $10B acquisition of Verona Pharma, adding Ohtuvayre — the first new inhaled COPD therapy in over 20 years.

The final session of the symposium, "Impact on Chest Wall and Respiratory Muscles," was presented by Professor Peter T. Macklem, of the Meakins-Christie Labs at McGill University Health Center in ...

Airways dysanapsis, a mismatch between airway calibre and lung volume, has long been observed as a physiological variant ...